Home > Category > Signaling Pathways > Stem Cells & Wnt

Stem Cells & Wnt

36 related results
Display mode
All
All
ProductNum picture CAS No. Name and description Formula Quick order
CL2888A
905854-03-7

(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198

98+%

C23H19N3O2
CL2884
936091-14-4

TG101209

98+%

C26H35N7O2S
CL1006C
2109414-84-6

Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride

98+%

C22H18Cl2N8·2HCl
CL2733A
2109704-99-4

Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate)

98+%

C27H28N6O5S
CL2709
1422144-42-0

Netarsudil dimesylate ( AR-13324 dimesylate)

98+%

C30H35N3O9S2
CL2247A
2050057-56-0

Upadacitinib hemihydrate

98+%

C34H40F6N12O3
CL2693
1792180-81-4

Ritlecitinib

98+%

C15H19N5O
CL2693A
2192215-81-7

Ritlecitinib Tosylate

98+%

C22H27N5O4S
CL2655
1263774-59-9

Delgocitinib | JTE-052 | Corectim

98+%

C16H18N6O
CL2547
83280-65-3

Napabucasin(BBI608)

98+%

C14H8O4
CL2531
1640292-55-2

Oclacitinib Maleate (PF-03394197 Maleate)

98+%

C19H27N5O6S
CL2506
40391-99-9

Pamidronic Acid

C3H11NO7P2
CL1014B
485-19-8

Reticuline

98+%

C19H23NO4
CL2425
425386-60-3

Semagacestat (LY450139)

98+%

C19H27N3O4
CLA1355
1447814-75-6

Brontictuzumab (Anti-NOTCH1)

95+%

CLA1337
1345009-45-1

Vantictumab (Anti-FZD)

95+%

CLA1334
1359940-55-8

Tarextumab (Anti-NOTCH3)

95+%

CLA1299
1243262-17-0

Demcizumab (Anti-DLL4)

95+%

CL2221
1226056-71-8

Thiazovivin

98+%

C15H13N5OS
HL1389
88495-63-0

Artesunate

98+%

C19H28O8
1 2
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays